BJD Editor's Choice  by unknown
BJD EDITOR'S CHOICE
© 2014 British Association of Dermatologists www.jidonline.org 329
from the British Journal of Dermatology
Evidence-based guidelines for  
laboratory screening for infectious 
diseases before initiation of systemic 
immunosuppressive agents in patients  
with autoimmune bullous dermatoses
This study from dermatologists of the Mayo Clinic in the 
U.S.A. aimed to establish evidence-based guidelines for 
pretreatment testing for infectious diseases in patients with 
autoimmune bullous dermatoses (ABDs). The authors state 
that there are no pretreatment infection testing guidelines 
available for clinicians caring for patients with ABDs. They 
performed a systematic literature review in other medical 
disciplines that use similar iatrogenic immunosuppressive 
medications to treat various diseases and conditions. They 
used this to develop infection testing recommendations for 
patients with ABDs before initiating immunosuppressive 
therapy. They state that assessing individual patient risk fac-
tors for latent infection and preventable communicable 
diseases can direct testing for selected infections before start-
ing immunosuppressive therapy. They conclude that testing 
patients with ABDs should include investigation for hepati-
tis B virus, hepatitis C virus and Mycobacterium tuberculosis 
infection before initiating rituximab treatment. Br J Dermatol 
2014; 171: 1307–1317.
Hand eczema prognosis and consequences:  
a 7-year follow-up study
The authors of this study from Denmark state that hand ecze-
ma is a common and long-lasting disease with impacts on 
the patient and society. The aims of their 7-year follow-up 
study were to evaluate the clinical course of patients with 
hand eczema, to assess the occupational consequences and 
to identify risk factors associated with a poor prognosis. They 
followed up 536 patients who were all examined by a der-
matologist and diagnosed as suffering from hand eczema. 
Based on the photographic guide, 73% of the 536 patients 
experienced a clinical improvement over the 7-year period. 
However, 20% of the cohort still had moderate-to-very-
severe hand eczema at follow-up. Severe hand eczema at 
baseline, frequent eruptions at baseline and eczema in other 
body locations during the follow-up period were risk factors 
for a poor prognosis, occupational consequences and low 
health-related quality of life. Being a woman was associated 
with occupational consequences and impaired health-related 
quality of life. The authors concluded that overall, the disease 
had improved 7 years after the dermatological examination. 
Nevertheless, many patients continued to have symptoms. The 
authors state that special attention should be given to the sub-
groups of patients at greater risk of a poor outcome: women, 
patients with frequent eruptions, those with severe hand ecze-
ma at outset and patients with more widespread eczema. Br J 
Dermatol 2014; 171: 1428–1433.
Alcohol intake and early-onset basal cell 
carcinoma in a case–control study
This study by researchers from Yale, U.S.A. states that existing 
evidence on an association between alcohol intake and basal 
cell carcinoma (BCC) is mixed, with several cohort studies 
finding an increased risk, but one cohort and several case–con-
trol studies observing no association. They explain that some of 
this evidence indicates that the association may differ by type of 
alcoholic beverage. Their study is the first investigation of alco-
hol intake in relation to early-onset BCC among people under 
the age of 40 years. They conducted an exploratory evaluation 
of effect modification by ultraviolet (UV) radiation exposure, 
as alcohol may enhance the carcinogenicity of UV radiation. 
They report no overall association between alcohol and BCC. 
They conclude that although no clear association between life-
time alcohol intake and early-onset BCC was observed, their 
exploratory interaction analyses have still provided intriguing 
data for future studies evaluating alcohol, UV and skin cancer. 
Br J Dermatol 2014; 171: 1451–1457.
Fascia excision is not necessary  
for thick melanomas
These researchers from the University of Bern, Switzerland 
set out to determine whether deep excision of melanoma 
improved patients’ prognoses. They highlight that melanoma 
has changed over recent decades from being an uncommon 
malignancy to a major health issue worldwide. They state that 
surgical treatment with a wide excision margin of the mela-
noma is the standard of care for all primary melanomas. Their 
study was a retrospective analysis of patients with thick mela-
nomas over a 16-year period. They included patients who 
underwent excision with a 1-cm margin, according to their 
local guidelines and previous publications. They collected 
data on patients’ sex, age, tumour location, tumour type and 
Breslow depth, and the presence of ulceration. They compared 
local recurrences, locoregional and distant metastases, and dis-
ease-free and overall survival between the fascia-excised and 
the fascia-preserved groups. They concluded that excision of 
the deep fascia in their patients with thick melanoma did not 
improve the outcome. Br J Dermatol 2014; 171: 1391–1396.
